SecBot SecBot
Institutional Cluster

BCRX

BIOCRYST PHARMACEUTICALS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed1d 13h ago
Institutional cluster: 3 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is small and passive in nature, with no activist or insider signal. Monitor next 13F for continuation or reversal of this modest accumulation, and watch for any corporate catalyst (pipeline data, FDA decision) that could explain the shared thesis.

DirectionNeutral
Confidencemedium
Horizonweeks

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three institutional asset managers increased their BCRX positions in Q3 2026, adding a net $1.9M in holdings, while one advisor trimmed $472K. The cluster is modestly bullish but lacks insider corroboration and reflects stale quarter-end data.

Key Financial Metrics

Direction
accumulating
Buy Value
$11.1M
Sell Value
$681.0K
Net Flow
$1.9M

Institutional Positions

Net institutional flow: $1.9M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Strs OhioADD+82.2%$1.4M$461.0K
Principal Financial GroupADD+52.7%$6.0M$1.3M
Assenagon Asset ManagementADD+27.2%$3.7M$210.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Wealth Enhancement Advisory ServicesTRIM-61.3%$681.0K-$472.0K

Key Facts

  • 3 institutional buyers added $1.9M in net value during Q3 2026
  • 1 seller trimmed $472K, representing the only bearish move
  • All buyers are asset managers (Strs Ohio, Principal Financial, Assenagon), no activist or hedge fund participation
  • No open-market insider buying was detected in the same window (confluence score 12/100)
  • 13F data is stale by ~45 days; positions may have been unwound since quarter-end

Financial Impact

Net institutional accumulation of $1.4M across 3 buyers vs $472K in selling, for a net inflow of ~$1.9M

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; current positions may differ materially
  • No insider buying to corroborate institutional conviction
  • Cluster size is small relative to BCRX's $2.2B market cap

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BCRX-2026-Q3
17 reports for BCRX
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +21.01%Feb 26, 2026
Filters
Rows
Reports for BCRX, sortable and filterable
TypeNow
Nov 4, 2026
today
8-K
BULLISH ★ 6/10
No priceawaiting T+60awaiting T+60No price
Nov 4, 2026
today
Press Release
BULLISH ★ 6/10
$8.64awaiting T+60awaiting T+60No price
Nov 2, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 3/10
$8.14awaiting T+60awaiting T+60No price
Oct 27, 2026
7d ago
Institutional Cluster
MIXED ★ 3/10
$8.37awaiting T+60awaiting T+60No price
Oct 21, 2026
13d ago
Press Release
NEUTRAL ★ 1/10
$7.78awaiting T+60awaiting T+60No price
Aug 5, 2026
13w ago
8-K
BULLISH ★ 7/10
$9.07 $8.46▼ −6.73%▼ −6.92%No price
Jun 29, 2026
18w ago
8-K
NEUTRAL ★ 5/10
$9.55 $8.78▼ −8.06%▼ −12.45%No price
Jun 12, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$9.06 $8.81▼ −2.81%▼ −3.82%No price
Jun 12, 2026
20w ago
Press Release
NEUTRAL ★ 4/10
$8.70 $9.07▲ +4.20%▲ +0.93%No price
May 19, 2026
24w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.74 $9.74▲ +11.44%▲ +6.44%No price
Showing 10 of 17

US Market Status

Market Closed · Opens in 1h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026